|Description||CTP-347 is a labelled analogue of Paroxetine. CTP-347 was developed for the treatment of hot flashes yet the phase I clinical trial was halted in 2013.|
|Current Developer||Concert Pharmaceuticals|
A labelled impurity of Paroxetine which is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.
CTP-347 is a labelled analogue of Paroxetine. CTP-347 was developed for the treatment of hot flashes yet the phase I clinical trial was halted in 2013.
An isotope labelled derivative of Paroxetine. Paroxetine is an antidepressant as a selective serotonin reuptake inhibitor.
A labelled impurity of Paroxetine which is the first antidepressant to treat panic disorder formally approved in the United States.